Exclusive: NewLink says Ebola vaccine trial could start in weeks

August 13, 2014 5:23 PM

14
0

(Reuters) - NewLink Genetics Corp (NLNK.O), which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.

The company has also lined up two contract manufacturing companies and possibly a third and will be able to produce tens of thousands of doses of the vaccine within "the next month or two," Dr Charles Link said in an interview.